Global IBS-C Drugs Market Size, Status and Forecast 2022

Publisher Name :
Date: 03-Oct-2017
No. of pages: 118
Inquire Before Buying

This report studies the global IBS-C Drugs market, analyzes and researches the IBS-C Drugs development status and forecast in United States, EU, Japan, China, India and Southeast Asia. This report focuses on the top players in global market, like

- Catalent Pharmaceuticals Solutions

- Nestle

- Abbott Laboratories

- Synergy Pharmaceuticals

- Sucampo Pharmaceuticals

- Novartis Pharma Ag

- Astellas Pharmaceuticals

- Ardelyx, Inc

- Synthetic Biologics, Inc

- Teva Pharmaceutical Industries

- Bama-Geve, SLU

- Ferring BV

- Ironwood Pharmaceuticals, Inc

- Salix Pharmaceuticals Ltd

- Norgine B.V

- Prometheus Laboratories Inc

- Actavis Nordic A/S

- Albireo Pharma Inc

- Yuhan Corp

- Astrazeneca Plc

- The Menarini Group

- Ono Pharmaceutical Co., Ltd

Market segment by Regions/Countries, this report covers

- United States

- EU

- Japan

- China

- India

- Southeast Asia

Market segment by Type, IBS-C Drugs can be split into

- Linaclotide

- Lubiprostone

- Osmotic Laxatives

- Stimulant Laxatives

- Other

Market segment by Application, IBS-C Drugs can be split into

- Hospital Pharmacies

- Retail Pharmacies

- Online Pharmacies

If you have any special requirements, please let us know and we will offer you the report as you want.

Global IBS-C Drugs Market Size, Status and Forecast 2022

Table of Contents
Global IBS-C Drugs Market Size, Status and Forecast 2022
1 Industry Overview of IBS-C Drugs
1.1 IBS-C Drugs Market Overview
1.1.1 IBS-C Drugs Product Scope
1.1.2 Market Status and Outlook
1.2 Global IBS-C Drugs Market Size and Analysis by Regions
1.2.1 United States
1.2.2 EU
1.2.3 Japan
1.2.4 China
1.2.5 India
1.2.6 Southeast Asia
1.3 IBS-C Drugs Market by Type
1.3.1 Linaclotide
1.3.2 Lubiprostone
1.3.3 Osmotic Laxatives
1.3.4 Stimulant Laxatives
1.3.5 Other
1.4 IBS-C Drugs Market by End Users/Application
1.4.1 Hospital Pharmacies
1.4.2 Retail Pharmacies
1.4.3 Online Pharmacies
2 Global IBS-C Drugs Competition Analysis by Players
2.1 IBS-C Drugs Market Size (Value) by Players (2016 and 2017)
2.2 Competitive Status and Trend
2.2.1 Market Concentration Rate
2.2.2 Product/Service Differences
2.2.3 New Entrants
2.2.4 The Technology Trends in Future
3 Company (Top Players) Profiles
3.1 Catalent Pharmaceuticals Solutions
3.1.1 Company Profile
3.1.2 Main Business/Business Overview
3.1.3 Products, Services and Solutions
3.1.4 IBS-C Drugs Revenue (Value) (2012-2017)
3.1.5 Recent Developments
3.2 Nestle
3.2.1 Company Profile
3.2.2 Main Business/Business Overview
3.2.3 Products, Services and Solutions
3.2.4 IBS-C Drugs Revenue (Value) (2012-2017)
3.2.5 Recent Developments
3.3 Abbott Laboratories
3.3.1 Company Profile
3.3.2 Main Business/Business Overview
3.3.3 Products, Services and Solutions
3.3.4 IBS-C Drugs Revenue (Value) (2012-2017)
3.3.5 Recent Developments
3.4 Synergy Pharmaceuticals
3.4.1 Company Profile
3.4.2 Main Business/Business Overview
3.4.3 Products, Services and Solutions
3.4.4 IBS-C Drugs Revenue (Value) (2012-2017)
3.4.5 Recent Developments
3.5 Sucampo Pharmaceuticals
3.5.1 Company Profile
3.5.2 Main Business/Business Overview
3.5.3 Products, Services and Solutions
3.5.4 IBS-C Drugs Revenue (Value) (2012-2017)
3.5.5 Recent Developments
3.6 Novartis Pharma Ag
3.6.1 Company Profile
3.6.2 Main Business/Business Overview
3.6.3 Products, Services and Solutions
3.6.4 IBS-C Drugs Revenue (Value) (2012-2017)
3.6.5 Recent Developments
3.7 Astellas Pharmaceuticals
3.7.1 Company Profile
3.7.2 Main Business/Business Overview
3.7.3 Products, Services and Solutions
3.7.4 IBS-C Drugs Revenue (Value) (2012-2017)
3.7.5 Recent Developments
3.8 Ardelyx, Inc
3.8.1 Company Profile
3.8.2 Main Business/Business Overview
3.8.3 Products, Services and Solutions
3.8.4 IBS-C Drugs Revenue (Value) (2012-2017)
3.8.5 Recent Developments
3.9 Synthetic Biologics, Inc
3.9.1 Company Profile
3.9.2 Main Business/Business Overview
3.9.3 Products, Services and Solutions
3.9.4 IBS-C Drugs Revenue (Value) (2012-2017)
3.9.5 Recent Developments
3.10 Teva Pharmaceutical Industries
3.10.1 Company Profile
3.10.2 Main Business/Business Overview
3.10.3 Products, Services and Solutions
3.10.4 IBS-C Drugs Revenue (Value) (2012-2017)
3.10.5 Recent Developments
3.11 Bama-Geve, SLU
3.12 Ferring BV
3.13 Ironwood Pharmaceuticals, Inc
3.14 Salix Pharmaceuticals Ltd
3.15 Norgine B.V
3.16 Prometheus Laboratories Inc
3.17 Actavis Nordic A/S
3.18 Albireo Pharma Inc
3.19 Yuhan Corp
3.20 Astrazeneca Plc
3.21 The Menarini Group
3.22 Ono Pharmaceutical Co., Ltd
4 Global IBS-C Drugs Market Size by Type and Application (2012-2017)
4.1 Global IBS-C Drugs Market Size by Type (2012-2017)
4.2 Global IBS-C Drugs Market Size by Application (2012-2017)
4.3 Potential Application of IBS-C Drugs in Future
4.4 Top Consumer/End Users of IBS-C Drugs
5 United States IBS-C Drugs Development Status and Outlook
5.1 United States IBS-C Drugs Market Size (2012-2017)
5.2 United States IBS-C Drugs Market Size and Market Share by Players (2016 and 2017)
6 EU IBS-C Drugs Development Status and Outlook
6.1 EU IBS-C Drugs Market Size (2012-2017)
6.2 EU IBS-C Drugs Market Size and Market Share by Players (2016 and 2017)
7 Japan IBS-C Drugs Development Status and Outlook
7.1 Japan IBS-C Drugs Market Size (2012-2017)
7.2 Japan IBS-C Drugs Market Size and Market Share by Players (2016 and 2017)
8 China IBS-C Drugs Development Status and Outlook
8.1 China IBS-C Drugs Market Size (2012-2017)
8.2 China IBS-C Drugs Market Size and Market Share by Players (2016 and 2017)
9 India IBS-C Drugs Development Status and Outlook
9.1 India IBS-C Drugs Market Size (2012-2017)
9.2 India IBS-C Drugs Market Size and Market Share by Players (2016 and 2017)
10 Southeast Asia IBS-C Drugs Development Status and Outlook
10.1 Southeast Asia IBS-C Drugs Market Size (2012-2017)
10.2 Southeast Asia IBS-C Drugs Market Size and Market Share by Players (2016 and 2017)
11 Market Forecast by Regions, Type and Application (2017-2022)
11.1 Global IBS-C Drugs Market Size (Value) by Regions (2017-2022)
11.1.1 United States IBS-C Drugs Revenue and Growth Rate (2017-2022)
11.1.2 EU IBS-C Drugs Revenue and Growth Rate (2017-2022)
11.1.3 Japan IBS-C Drugs Revenue and Growth Rate (2017-2022)
11.1.4 China IBS-C Drugs Revenue and Growth Rate (2017-2022)
11.1.5 India IBS-C Drugs Revenue and Growth Rate (2017-2022)
11.1.6 Southeast Asia IBS-C Drugs Revenue and Growth Rate (2017-2022)
11.2 Global IBS-C Drugs Market Size (Value) by Type (2017-2022)
11.3 Global IBS-C Drugs Market Size by Application (2017-2022)
12 IBS-C Drugs Market Dynamics
12.1 IBS-C Drugs Market Opportunities
12.2 IBS-C Drugs Challenge and Risk
12.2.1 Competition from Opponents
12.2.2 Downside Risks of Economy
12.3 IBS-C Drugs Market Constraints and Threat
12.3.1 Threat from Substitute
12.3.2 Government Policy
12.3.3 Technology Risks
12.4 IBS-C Drugs Market Driving Force
12.4.1 Growing Demand from Emerging Markets
12.4.2 Potential Application
13 Market Effect Factors Analysis
13.1 Technology Progress/Risk
13.1.1 Substitutes
13.1.2 Technology Progress in Related Industry
13.2 Consumer Needs Trend/Customer Preference
13.3 External Environmental Change
13.3.1 Economic Fluctuations
13.3.2 Other Risk Factors
14 Research Finding/Conclusion
15 Appendix
Methodology
Analyst Introduction
Data Source
List of Tables and Figures
Figure IBS-C Drugs Product Scope
Figure Global IBS-C Drugs Market Size (Million USD) (2012-2017)
Table Global IBS-C Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure Global IBS-C Drugs Market Share by Regions in 2016
Figure United States IBS-C Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure EU IBS-C Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure Japan IBS-C Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure China IBS-C Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure India IBS-C Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure Southeast Asia IBS-C Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure Global IBS-C Drugs Market Share by Type in 2016
Figure Linaclotide Market Size (Million USD) and Growth Rate (2012-2017)
Figure Lubiprostone Market Size (Million USD) and Growth Rate (2012-2017)
Figure Osmotic Laxatives Market Size (Million USD) and Growth Rate (2012-2017)
Figure Stimulant Laxatives Market Size (Million USD) and Growth Rate (2012-2017)
Figure Other Market Size (Million USD) and Growth Rate (2012-2017)
Figure Global IBS-C Drugs Market Share by Application in 2016
Table Key Downstream Customer in Hospital Pharmacies
Figure IBS-C Drugs Market Size (Million USD) and Growth Rate in Hospital Pharmacies (2012-2017)
Table Key Downstream Customer in Retail Pharmacies
Figure IBS-C Drugs Market Size (Million USD) and Growth Rate in Retail Pharmacies (2012-2017)
Table Key Downstream Customer in Online Pharmacies
Figure IBS-C Drugs Market Size (Million USD) and Growth Rate in Online Pharmacies (2012-2017)
Table IBS-C Drugs Market Size (Million USD) by Players (2016 and 2017)
Figure IBS-C Drugs Market Size Share by Players in 2016
Figure IBS-C Drugs Market Size Share by Players in 2017
Table Catalent Pharmaceuticals Solutions Basic Information List
Table IBS-C Drugs Business Revenue (Million USD) of Catalent Pharmaceuticals Solutions (2012-2017)
Figure Catalent Pharmaceuticals Solutions IBS-C Drugs Business Revenue Market Share in 2016
Table Nestle Basic Information List
Table IBS-C Drugs Business Revenue (Million USD) of Nestle (2012-2017)
Figure Nestle IBS-C Drugs Business Revenue Market Share in 2016
Table Abbott Laboratories Basic Information List
Table IBS-C Drugs Business Revenue (Million USD) of Abbott Laboratories (2012-2017)
Figure Abbott Laboratories IBS-C Drugs Business Revenue Market Share in 2016
Table Synergy Pharmaceuticals Basic Information List
Table IBS-C Drugs Business Revenue (Million USD) of Synergy Pharmaceuticals (2012-2017)
Figure Synergy Pharmaceuticals IBS-C Drugs Business Revenue Market Share in 2016
Table Sucampo Pharmaceuticals Basic Information List
Table IBS-C Drugs Business Revenue (Million USD) of Sucampo Pharmaceuticals (2012-2017)
Figure Sucampo Pharmaceuticals IBS-C Drugs Business Revenue Market Share in 2016
Table Novartis Pharma Ag Basic Information List
Table IBS-C Drugs Business Revenue (Million USD) of Novartis Pharma Ag (2012-2017)
Figure Novartis Pharma Ag IBS-C Drugs Business Revenue Market Share in 2016
Table Astellas Pharmaceuticals Basic Information List
Table IBS-C Drugs Business Revenue (Million USD) of Astellas Pharmaceuticals (2012-2017)
Figure Astellas Pharmaceuticals IBS-C Drugs Business Revenue Market Share in 2016
Table Ardelyx, Inc Basic Information List
Table IBS-C Drugs Business Revenue (Million USD) of Ardelyx, Inc (2012-2017)
Figure Ardelyx, Inc IBS-C Drugs Business Revenue Market Share in 2016
Table Synthetic Biologics, Inc Basic Information List
Table IBS-C Drugs Business Revenue (Million USD) of Synthetic Biologics, Inc (2012-2017)
Figure Synthetic Biologics, Inc IBS-C Drugs Business Revenue Market Share in 2016
Table Teva Pharmaceutical Industries Basic Information List
Table IBS-C Drugs Business Revenue (Million USD) of Teva Pharmaceutical Industries (2012-2017)
Figure Teva Pharmaceutical Industries IBS-C Drugs Business Revenue Market Share in 2016
Table Bama-Geve, SLU Basic Information List
Table IBS-C Drugs Business Revenue (Million USD) of Bama-Geve, SLU (2012-2017)
Figure Bama-Geve, SLU IBS-C Drugs Business Revenue Market Share in 2016
Table Ferring BV Basic Information List
Table IBS-C Drugs Business Revenue (Million USD) of Ferring BV (2012-2017)
Figure Ferring BV IBS-C Drugs Business Revenue Market Share in 2016
Table Ironwood Pharmaceuticals, Inc Basic Information List
Table IBS-C Drugs Business Revenue (Million USD) of Ironwood Pharmaceuticals, Inc (2012-2017)
Figure Ironwood Pharmaceuticals, Inc IBS-C Drugs Business Revenue Market Share in 2016
Table Salix Pharmaceuticals Ltd Basic Information List
Table IBS-C Drugs Business Revenue (Million USD) of Salix Pharmaceuticals Ltd (2012-2017)
Figure Salix Pharmaceuticals Ltd IBS-C Drugs Business Revenue Market Share in 2016
Table Norgine B.V Basic Information List
Table IBS-C Drugs Business Revenue (Million USD) of Norgine B.V (2012-2017)
Figure Norgine B.V IBS-C Drugs Business Revenue Market Share in 2016
Table Prometheus Laboratories Inc Basic Information List
Table IBS-C Drugs Business Revenue (Million USD) of Prometheus Laboratories Inc (2012-2017)
Figure Prometheus Laboratories Inc IBS-C Drugs Business Revenue Market Share in 2016
Table Actavis Nordic A/S Basic Information List
Table IBS-C Drugs Business Revenue (Million USD) of Actavis Nordic A/S (2012-2017)
Figure Actavis Nordic A/S IBS-C Drugs Business Revenue Market Share in 2016
Table Albireo Pharma Inc Basic Information List
Table IBS-C Drugs Business Revenue (Million USD) of Albireo Pharma Inc (2012-2017)
Figure Albireo Pharma Inc IBS-C Drugs Business Revenue Market Share in 2016
Table Yuhan Corp Basic Information List
Table IBS-C Drugs Business Revenue (Million USD) of Yuhan Corp (2012-2017)
Figure Yuhan Corp IBS-C Drugs Business Revenue Market Share in 2016
Table Astrazeneca Plc Basic Information List
Table IBS-C Drugs Business Revenue (Million USD) of Astrazeneca Plc (2012-2017)
Figure Astrazeneca Plc IBS-C Drugs Business Revenue Market Share in 2016
Table The Menarini Group Basic Information List
Table IBS-C Drugs Business Revenue (Million USD) of The Menarini Group (2012-2017)
Figure The Menarini Group IBS-C Drugs Business Revenue Market Share in 2016
Table Ono Pharmaceutical Co., Ltd Basic Information List
Table IBS-C Drugs Business Revenue (Million USD) of Ono Pharmaceutical Co., Ltd (2012-2017)
Figure Ono Pharmaceutical Co., Ltd IBS-C Drugs Business Revenue Market Share in 2016
Table Global IBS-C Drugs Market Size (Million USD) by Type (2012-2017)
Figure Global IBS-C Drugs Market Size Share by Type in 2012
Figure Global IBS-C Drugs Market Size Share by Type in 2013
Figure Global IBS-C Drugs Market Size Share by Type in 2014
Figure Global IBS-C Drugs Market Size Share by Type in 2015
Figure Global IBS-C Drugs Market Size Share by Type in 2016
Figure Global IBS-C Drugs Market Size Share by Type in 2017
Table Global IBS-C Drugs Market Size (Million USD) by Application (2012-2017)
Figure Global IBS-C Drugs Market Size (Million USD) by Application in 2012
Figure Global IBS-C Drugs Market Size (Million USD) by Application in 2013
Figure Global IBS-C Drugs Market Size (Million USD) by Application in 2014
Figure Global IBS-C Drugs Market Size (Million USD) by Application in 2015
Figure Global IBS-C Drugs Market Size (Million USD) by Application in 2016
Figure Global IBS-C Drugs Market Size (Million USD) by Application in 2017
Table Top Consumer/End Users of IBS-C Drugs
Figure United States IBS-C Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table United States IBS-C Drugs Market Size (Million USD) by Players (2012-2017)
Figure United States IBS-C Drugs Market Size Share by Players in 2016
Figure United States IBS-C Drugs Market Size Share by Players in 2017
Figure EU IBS-C Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table EU IBS-C Drugs Market Size (Million USD) by Players (2012-2017)
Figure EU IBS-C Drugs Market Size Share by Players in 2016
Figure EU IBS-C Drugs Market Size Share by Players in 2017
Figure Japan IBS-C Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table Japan IBS-C Drugs Market Size (Million USD) by Players (2012-2017)
Figure Japan IBS-C Drugs Market Size Share by Players in 2016
Figure Japan IBS-C Drugs Market Size Share by Players in 2017
Figure China IBS-C Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table China IBS-C Drugs Market Size (Million USD) by Players (2012-2017)
Figure China IBS-C Drugs Market Size Share by Players in 2016
Figure China IBS-C Drugs Market Size Share by Players in 2017
Figure India IBS-C Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table India IBS-C Drugs Market Size (Million USD) by Players (2012-2017)
Figure India IBS-C Drugs Market Size Share by Players in 2016
Figure India IBS-C Drugs Market Size Share by Players in 2017
Figure Southeast Asia IBS-C Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table Southeast Asia IBS-C Drugs Market Size (Million USD) by Players (2012-2017)
Figure Southeast Asia IBS-C Drugs Market Size Share by Players in 2016
Figure Southeast Asia IBS-C Drugs Market Size Share by Players in 2017
Figure Global IBS-C Drugs Market Size (Million USD) by Regions (2017-2022)
Table Global IBS-C Drugs Market Size (Million USD) by Regions (2017-2022)
Figure Global IBS-C Drugs Market Size Share by Regions in 2017
Figure Global IBS-C Drugs Market Size Share by Regions in 2022
Figure United States IBS-C Drugs Revenue (Million USD) and Growth Rate (2017-2022)
Figure EU IBS-C Drugs Revenue (Million USD) and Growth Rate (2017-2022)
Figure Japan IBS-C Drugs Revenue (Million USD) and Growth Rate (2017-2022)
Figure China IBS-C Drugs Revenue (Million USD) and Growth Rate (2017-2022)
Figure India IBS-C Drugs Revenue (Million USD) and Growth Rate (2017-2022)
Figure Southeast Asia IBS-C Drugs Revenue (Million USD) and Growth Rate (2017-2022)
Table Global IBS-C Drugs Market Size (Million USD) by Type (2017-2022)
Figure Global IBS-C Drugs Market Size Share by Type in 2017
Figure Global IBS-C Drugs Market Size Share by Type in 2022
Table Global IBS-C Drugs Market Size (Million USD) by Application (2017-2022)
Figure Global IBS-C Drugs Market Size (Million USD) by Application in 2017
Figure Global IBS-C Drugs Market Size (Million USD) by Application in 2022
  • Global Pizotifen Market Research Report 2018
    Published: 18-Jul-2018        Price: US 2900 Onwards        Pages: 99
    This report studies the global Pizotifen market status and forecast, categorizes the global Pizotifen market size (value & volume) by key players, type, application, and region. This report focuses on the top players in North America, Europe, Asia-Pacific, South America, and Middle East & Africa. The global Pizotifen market is valued at million US$ in 2017 and will reach million US$ by the end of 2025, growing at a CAGR of during 2018-2025. The major manufacturer......
  • Tyrosine Protein Kinase Receptor TYRO3 (Tyrosine Protein Kinase BYK or Tyrosine Protein Kinase DTK or Tyrosine Protein Kinase RSE or Tyrosine Protein Kinase TIF or Tyrosine Protein Kinase SKY or TYRO3 or EC 2.7.10.1) - Pipeline Review, H2 2018
    Published: 17-Jul-2018        Price: US 3500 Onwards        Pages: 35
    Tyrosine Protein Kinase Receptor TYRO3 (Tyrosine Protein Kinase BYK or Tyrosine Protein Kinase DTK or Tyrosine Protein Kinase RSE or Tyrosine Protein Kinase TIF or Tyrosine Protein Kinase SKY or TYRO3 or EC 2.7.10.1) - Pipeline Review, H2 2018 Summary Tyrosine Protein Kinase Receptor TYRO3 (Tyrosine Protein Kinase BYK or Tyrosine Protein Kinase DTK or Tyrosine Protein Kinase RSE or Tyrosine Protein Kinase TIF or Tyrosine Protein Kinase SKY or TYRO3 or EC 2.7.10.1) pipel......
  • Protein Glutamine Gamma Glutamyltransferase 2 (Tissue Transglutaminase or Transglutaminase C or Transglutaminase H or Transglutaminase 2 or TGase C or TGase H or TGM2 or EC 2.3.2.13) - Pipeline Review, H2 2018
    Published: 17-Jul-2018        Price: US 3500 Onwards        Pages: 37
    Protein Glutamine Gamma Glutamyltransferase 2 (Tissue Transglutaminase or Transglutaminase C or Transglutaminase H or Transglutaminase 2 or TGase C or TGase H or TGM2 or EC 2.3.2.13) - Pipeline Review, H2 2018 Summary Protein Glutamine Gamma Glutamyltransferase 2 (Tissue Transglutaminase or Transglutaminase C or Transglutaminase H or Transglutaminase 2 or TGase C or TGase H or TGM2 or EC 2.3.2.13) - Transglutaminase 2 (TG2) is a member of the transglutaminase family tha......
  • Respiratory Syncytial Virus Attachment Glycoprotein (RSV G or G) - Pipeline Review, H2 2018
    Published: 17-Jul-2018        Price: US 3500 Onwards        Pages: 40
    Respiratory Syncytial Virus Attachment Glycoprotein (RSV G or G) - Pipeline Review, H2 2018 Summary Respiratory Syncytial Virus Attachment Glycoprotein (RSV G or G) - Respiratory syncytial virus G protein is a protein produced by respiratory syncytial virus. It attaches the virion to the host cell membrane by interacting with heparan sulfate. It interacts with host CX3CR1, the receptor for the CX3C chemokine fractalkine, to modulate the immune response and facilitate in......
  • Survival Motor Neuron Protein (Component Of Gems 1 or Gemin 1 or SMN1 or SMN2) - Pipeline Review, H2 2018
    Published: 17-Jul-2018        Price: US 3500 Onwards        Pages: 70
    Survival Motor Neuron Protein (Component Of Gems 1 or Gemin 1 or SMN1 or SMN2) - Pipeline Review, H2 2018 Summary Survival Motor Neuron Protein (Component Of Gems 1 or Gemin 1 or SMN1 or SMN2) pipeline Target constitutes close to 15 molecules. Out of which approximately 9 molecules are developed by companies and remaining by the universities/institutes. The latest report Survival Motor Neuron Protein - Pipeline Review, H2 2018, outlays comprehensive information on the S......
  • NT 3 Growth Factor Receptor (TrkC Tyrosine Kinase or GP145 TrkC or Neurotrophic Tyrosine Kinase Receptor Type 3 or NTRK3 or EC 2.7.10.1) - Pipeline Review, H2 2018
    Published: 17-Jul-2018        Price: US 3500 Onwards        Pages: 65
    NT 3 Growth Factor Receptor (TrkC Tyrosine Kinase or GP145 TrkC or Neurotrophic Tyrosine Kinase Receptor Type 3 or NTRK3 or EC 2.7.10.1) - Pipeline Review, H2 2018 Summary According to the recently published report 'NT 3 Growth Factor Receptor - Pipeline Review, H2 2018'; NT 3 Growth Factor Receptor (TrkC Tyrosine Kinase or GP145 TrkC or Neurotrophic Tyrosine Kinase Receptor Type 3 or NTRK3 or EC 2.7.10.1) pipeline Target constitutes close to 7 molecules. ......
  • MAP Kinase Interacting Serine/Threonine Protein Kinase 2 (MAP Kinase Signal Integrating Kinase 2 or MKNK2 or EC 2.7.11.1) - Pipeline Review, H2 2018
    Published: 17-Jul-2018        Price: US 3500 Onwards        Pages: 41
    MAP Kinase Interacting Serine/Threonine Protein Kinase 2 (MAP Kinase Signal Integrating Kinase 2 or MKNK2 or EC 2.7.11.1) - Pipeline Review, H2 2018 Summary MAP Kinase Interacting Serine/Threonine Protein Kinase 2 (MAP Kinase Signal Integrating Kinase 2 or MKNK2 or EC 2.7.11.1) - MAP kinase-interacting serine/threonine-protein kinase 2 is an enzyme encoded by the MKNK2 gene. It phosphorylates SFPQ/PSF, HNRNPA1 and EIF4E. It plays a role in the response to environmental ......
  • BDNF/NT 3 Growth Factors Receptor (GP145 TrkB or Neurotrophic Tyrosine Kinase Receptor Type 2 or TrkB Tyrosine Kinase or Tropomyosin Related Kinase B or NTRK2 or EC 2.7.10.1) - Pipeline Review, H2 2018
    Published: 17-Jul-2018        Price: US 3500 Onwards        Pages: 129
    BDNF/NT 3 Growth Factors Receptor (GP145 TrkB or Neurotrophic Tyrosine Kinase Receptor Type 2 or TrkB Tyrosine Kinase or Tropomyosin Related Kinase B or NTRK2 or EC 2.7.10.1) - Pipeline Review, H2 2018 Summary According to the recently published report 'BDNF NT 3 Growth Factors Receptor - Pipeline Review, H2 2018'; BDNF/NT 3 Growth Factors Receptor (GP145 TrkB or Neurotrophic Tyrosine Kinase Receptor Type 2 or TrkB Tyrosine Kinase or Tropomyosin Related Kinase B or NTRK......
  • Ephrin Type B Receptor 4 (Hepatoma Transmembrane Kinase or Tyrosine Protein Kinase TYRO11 or EPHB4 or EC 2.7.10.1) - Pipeline Review, H2 2018
    Published: 17-Jul-2018        Price: US 3500 Onwards        Pages: 48
    Ephrin Type B Receptor 4 (Hepatoma Transmembrane Kinase or Tyrosine Protein Kinase TYRO11 or EPHB4 or EC 2.7.10.1) - Pipeline Review, H2 2018 Summary According to the recently published report 'Ephrin Type B Receptor 4 - Pipeline Review, H2 2018'; Ephrin Type B Receptor 4 (Hepatoma Transmembrane Kinase or Tyrosine Protein Kinase TYRO11 or EPHB4 or EC 2.7.10.1) pipeline Target constitutes close to 6 molecules. Out of which approximately 3 molecules are developed by compa......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs